首页> 外文期刊>Public Health Nutrition >Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial
【24h】

Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial

机译:与铁和叶酸相比,在怀孕期间,在怀孕期间含有碘的多种微量营养素或小型脂质的营养补充剂的消耗,并不影响妇女马拉维农村的尿碘浓度:Ilins Dyad试验的次要结果分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Inadequate iodine intake during pregnancy increases the risk of neonatal morbidity and mortality. We aimed to evaluate whether prenatal supplements containing iodine affect urinary iodine concentrations (UIC) of pregnant women in Malawi. Design: A randomised controlled trial. Pregnant women (n 1391) were assigned to consume 60 mg/d Fe and 400 mu g/d folic acid (IFA) or 18 vitamins and minerals including 250 mu g/d iodine (MMN) or 20 g/d small-quantity lipid-based nutrient supplements (SQ-LNS) with similar nutrient contents as MMN group, plus macronutrients (LNS) until childbirth. In a sub-study (n 317), we evaluated group geometric mean urinary iodine concentration (UIC) (mu g/L) at 36 weeks of gestation controlling for baseline UIC and compared median (baseline) and geometric mean (36 weeks) UIC withWHOcut-offs: UIC < 150, 150-249, 250-499 and =500 reflecting insufficient, adequate, above requirements and excessive iodine intakes, respectively. Setting: Mangochi District, Malawi. Participants: Women =20 weeks pregnant. Results: Groups had comparable background characteristics. At baseline, overall median (Q1, Q3) UIC (319 (167, 559)) suggested iodine intakes above requirements. At 36 weeks, the geometric mean (95 % CI) UIC of the IFA (197 (171, 226)), MMN (212 (185, 243)) and LNS (220 (192, 253)) groups did not differ (P = 0.53) and reflected adequate intakes. Conclusions: In this setting, provision of supplements containing iodine at the recommended dose to pregnant women with relatively high iodine intakes at baseline, presumably from iodised salt, has no impact on the women's UIC. Regular monitoring of the iodine status of pregnant women in such settings is advisable. Clinicaltrials.gov identifier: NCT01239693.
机译:目的:孕期碘摄入不足会增加新生儿发病率和死亡率的风险。我们的目的是评估含有碘的产前补充剂是否会影响马拉维孕妇的尿碘浓度(UIC)。设计:随机对照试验。孕妇(n 1391)每天摄入60 mg/d铁和400μg/d叶酸(IFA)或18种维生素和矿物质,包括250μg/d碘(MMN)或20 g/d少量脂质营养补充剂(SQ-LNS),营养成分与MMN组相似,加上大量营养素(LNS),直到分娩。在一项子研究(n 317)中,我们评估了妊娠36周时的组几何平均尿碘浓度(UIC)(μg/L),对照基线UIC,并比较了中值(基线)和几何平均(36周)UIC与WHO截止值:UIC<150、150-249、250-499和=500,分别反映了碘摄入量不足、充足、高于要求和过量。环境:马拉维芒果奇区。参与者:女性=怀孕20周。结果:两组具有相似的背景特征。在基线检查时,总体中值(第一季度、第三季度)UIC(319(167559))表明碘摄入量高于要求。36周时,IFA(197(171226))、MMN(212(185243))和LNS(220(192253))组的几何平均值(95%可信区间)UIC没有差异(P=0.53),反映了摄入充足。结论:在这种情况下,以推荐剂量向基线碘摄入量相对较高的孕妇提供含碘补充剂(可能来自碘盐)对妇女的UIC没有影响。建议在此类环境中定期监测孕妇的碘状况。临床试验。政府识别码:NCT01239693。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号